Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novavax, Inc.

https://novavax.com/

Latest From Novavax, Inc.

COVID Vaccines: US FDA Changes Course, Wants New Formulas To Target KP.2 Subvariant ‘If Feasible’

Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’

Coronavirus COVID-19 Vaccines

Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid

Plus deals involving GSK/Elsie, Lilly/QurAlis, Gilead/Cartography as well as tech transfer announcements and deals in brief.

Deal Watch Business Strategies

Moderna Pips Pfizer/BioNTech In Combo Jab Race

The company reported a late-stage success with its COVID-19 and flu combo vaccine, and says it can hit the market next year.

Clinical Trials Vaccines

COVID-19 Vaccines: Novavax Gets Reprieve With US FDA Panel Supporting JN.1 Formulation

Advisory committee members said having Novavax’s protein-based vaccine available in the fall was important, but would not have been possible if a different variant strain were used. They also worried separate recommendations by vaccine type would cause confusion.

Advisory Committees Vaccines
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Liposomes
  • Other Names / Subsidiaries
    • CPL Biologicals Pvt. Ltd. (Joint Venture with Cadila)
    • Isconova AB
    • Novavax AB
UsernamePublicRestriction

Register